Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Trials. 2021 Sep 25;22(1):651. doi: 10.1186/s13063-021-05491-3.
Trials. 2021.
PMID: 34563240
Free PMC article.
Introducing new and repurposed TB drugs: the endTB experience.
Seung KJ, Khan U, Varaine F, Ahmed S, Bastard M, Cloez S, Damtew D, Franke MF, Herboczek K, Huerga H, Islam S, Karakozian H, Khachatryan N, Kliesckova J, Khan AJ, Khan M, Khan P, Kotrikadze T, Lachenal N, Lecca L, Lenggogeni P, Maretbayeva S, Melikyan N, Mesic A, Mitnick CD, Mofolo M, Perrin C, Richard M, Tassew YM, Telnov A, Vilbrun SC, Wanjala S, Rich ML, Hewison C.
Seung KJ, et al. Among authors: cloez s.
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1081-1086. doi: 10.5588/ijtld.20.0141.
Int J Tuberc Lung Dis. 2020.
PMID: 33126943
Item in Clipboard
Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries.
Perrin C, Cloez S, Dujardin C, Ravinetto R.
Perrin C, et al. Among authors: cloez s.
BMJ Glob Health. 2020 Jul;5(7):e003283. doi: 10.1136/bmjgh-2020-003283.
BMJ Glob Health. 2020.
PMID: 32713837
Free PMC article.
No abstract available.
Item in Clipboard
Poor-quality medicines in developing countries.
Ravinetto RM, Cloëz S, Scouflaire-Mallet SM, Vandenbergh D.
Ravinetto RM, et al. Among authors: cloez s.
Lancet Infect Dis. 2009 May;9(5):267-8. doi: 10.1016/S1473-3099(09)70090-8.
Lancet Infect Dis. 2009.
PMID: 19393953
Free article.
No abstract available.
Item in Clipboard
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L.
Patil SB, et al. Among authors: cloez s.
Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6.
Trials. 2023.
PMID: 38037119
Free PMC article.
Item in Clipboard
Cite
Cite